Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2014
11/06/2014US20140328940 Modulation of axon degeneration
11/06/2014US20140328924 Delivery of immunosuppressants having a specified pharmacodynamic effective-life and antigen for the induction of immune tolerance
11/06/2014US20140328923 Dosing combinations for reducing undesired humoral immune responses
11/06/2014US20140328922 Local, concomitant administration of tolerogenic synthetic nanocarriers to reduce type i and type iv hypersensitivity
11/06/2014US20140328921 Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen
11/06/2014US20140328904 Gla monotherapy for use in cancer treatment
11/06/2014US20140328880 Modified Pathogens For Use As Vaccines
11/06/2014US20140328877 West nile virus vaccine
11/06/2014US20140328876 Synthetic derivatives of mpl and uses thereof
11/06/2014US20140328875 Influenza virus vaccines and uses thereof
11/06/2014US20140328874 Sample quantification by disc centrifugation
11/06/2014US20140328873 Norovirus Immunogens and Related Materials and Methods
11/06/2014US20140328868 T-cell antigen peptide from allergen for stimulation of il-10 production
11/06/2014US20140328867 Microwave vacuum-drying of organic materials
11/06/2014US20140328866 Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier
11/06/2014US20140328865 Immune Modulation Via C-Type Lectin
11/06/2014US20140328863 Induction of Differential Stress Resistance and Uses Thereof
11/06/2014US20140328861 Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
11/06/2014US20140328859 Antibodies and methods for wnt pathway-related diseases
11/06/2014US20140328857 Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
11/06/2014US20140328856 Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
11/06/2014US20140328854 Tolerogenic synthetic nanocarriers and therapeutic macromolecules for reduced or enhanced pharmacodynamic effects
11/06/2014US20140328849 Anti-crth2 antibodies and methods of use
11/06/2014US20140328844 Methods of use for taci-immunoglobulin fusion proteins
11/06/2014US20140328843 Combination of FcgammaRIIB-Specific Antibodies and CD20-Specific Antibodies and Methods of Use Thereof
11/06/2014US20140328840 Marker and target for responsiveness and resistance to cancer agents
11/06/2014US20140328839 Methods For Reducing The Frequency And Severity Of Acute Exacerbations Of Asthma
11/06/2014US20140328837 Affinity Peptides Toward Infliximab
11/06/2014US20140328836 HER2/neu-Specific Antibodies and Methods of Using Same
11/06/2014US20140328835 Methods for treating retinopathy with extended therapeutic effect
11/06/2014US20140328834 Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor
11/06/2014US20140328832 Methods for treating cancer using combination therapy
11/06/2014US20140328831 Single domain tdf-related compounds and analogs thereof
11/06/2014US20140328829 Agr2 blocking antibody and use thereof
11/06/2014US20140328828 Use of therapeutic compositions comprising hyaluronan and therapeutic antibodies
11/06/2014US20140328820 Novel Class of Therapeutic Protein Based Molecules
11/06/2014US20140328797 Human rhinovirus (hrv) antibodies
11/06/2014US20140328750 Antibodies Reactive with B7-H3 and Uses Thereof
11/04/2014US8877914 Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes
11/04/2014US8877904 Chromatography purification of antibodies
11/04/2014US8877901 Camptothecin-binding moiety conjugates
11/04/2014US8877900 AX132 PCSK9 antagonists
11/04/2014US8877899 Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
11/04/2014US8877894 Modified beta-lactoglobulins for immunotherapy of milk allergy
11/04/2014US8877790 Allantoin-containing skin cream
11/04/2014US8877789 Allantoin-containing skin cream
11/04/2014US8877788 Allantoin-containing skin cream
11/04/2014US8877771 Treatment of solid tumors with rapamycin derivatives
11/04/2014US8877483 Dioxin elimination promoter
11/04/2014US8877456 Quantification of botulinum toxin
11/04/2014US8877448 Method of making recombinant influenza virus
11/04/2014US8877251 Powder compositions for inhalation
11/04/2014US8877213 Live attenuated Leishmania vaccines
11/04/2014US8877212 Use of an IL12 receptor-beta 1 splice variant to diagnose active tuberculosis
11/04/2014US8877211 Bovine herpes virus vaccine with multiple mutations
11/04/2014US8877210 Influenza hemagglutinin and neuraminidase variants
11/04/2014US8877209 Recombinant influenza vectors with tandem transcription units
11/04/2014US8877208 Multivalent nanoemulsion vaccines
11/04/2014US8877207 Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
11/04/2014US8877206 Stimulation of an immune response by cationic lipids
11/04/2014US8877205 Yeast-based therapeutic for chronic hepatitis B infection
11/04/2014US8877204 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
11/04/2014US8877202 Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
11/04/2014US8877201 Bordetella outer-membrane protein antigens and methods of making and using the same
11/04/2014US8877200 HA binding agents
11/04/2014US8877199 B cell surface reactive antibodies
11/04/2014US8877198 Methods of reducing phosphate absorption
11/04/2014US8877197 Anti-complement C1s
11/04/2014US8877196 Methods of altering bone growth by administration of sost or wise antagonist or agonist
11/04/2014US8877195 Monoclonal antibodies to fibrin
11/04/2014US8877194 TNF-α binding proteins
11/04/2014US8877193 Transdiscal administration of anti-TNFα antibodies and growth differentiation factors
11/04/2014US8877191 Antibodies to the PcrV antigen of Pseudomonas aeruginosa
11/04/2014US8877190 Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
11/04/2014US8877189 Binding members for interleukin-4 receptor alpha (IL-4Rα) - 173
11/04/2014US8877188 Detection and treatment of non-dermal fibrosis
11/04/2014US8877187 Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
11/04/2014US8877186 Polypeptides, antibody variable domains and antagonists
10/2014
10/30/2014US20140323693 Antibodies To Non-Functional P2X7 Receptor
10/30/2014US20140323688 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines
10/30/2014US20140322344 Vaccine preparation for cancer treatment
10/30/2014US20140322309 Alpha-aminoamidine polymers and uses thereof
10/30/2014US20140322301 Mucin antigen vaccine
10/30/2014US20140322297 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
10/30/2014US20140322274 Therapeutic Agents
10/30/2014US20140322272 Vaccine
10/30/2014US20140322271 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation
10/30/2014US20140322270 High yield yellow fever virus strain with increased propagation in cells
10/30/2014US20140322269 Engineered outer domain (eod) of hiv gp120 and mutants thereof
10/30/2014US20140322268 Synthetic glucopyranosyl lipid adjuvants
10/30/2014US20140322267 Orf2 protein of pcv2 subtype a (pcv2a) for use in cross-protection
10/30/2014US20140322266 Induction of mucosal tolerance to antigens
10/30/2014US20140322265 Recombinant poxvirus vector comprising tetanus toxin fragment c
10/30/2014US20140322264 Therapeutic vaccination against active tuberculosis
10/30/2014US20140322263 Pneumococcal dosing regimen
10/30/2014US20140322262 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/30/2014US20140322258 Polysaccharide-protein conjugate vaccines
10/30/2014US20140322256 Vaccine Candidates Against Johne's Disease
10/30/2014US20140322255 Second generation virus-like particles (vlp) from epstein-barr viruses for vaccination purposes
10/30/2014US20140322254 Polypeptide adjuvant
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 1823